Paraganglioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
These data (1) confirm that ART acts as a differentiation factor for autonomic (chiefly sympathoadrenal but also parasympathetic) neurons, (2) suggest a role for ART overexpression in the genesis of pheochromocytomas and paragangliomas, and (3) indicate that ART is not a suitable therapy for peripheral neuropathy.
|
15204970 |
2005 |
Peripheral Neuropathy
|
0.010 |
Biomarker
|
group |
BEFREE |
These data (1) confirm that ART acts as a differentiation factor for autonomic (chiefly sympathoadrenal but also parasympathetic) neurons, (2) suggest a role for ART overexpression in the genesis of pheochromocytomas and paragangliomas, and (3) indicate that ART is not a suitable therapy for peripheral neuropathy.
|
15204970 |
2005 |
Pheochromocytoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
These data (1) confirm that ART acts as a differentiation factor for autonomic (chiefly sympathoadrenal but also parasympathetic) neurons, (2) suggest a role for ART overexpression in the genesis of pheochromocytomas and paragangliomas, and (3) indicate that ART is not a suitable therapy for peripheral neuropathy.
|
15204970 |
2005 |
Adrenal Gland Pheochromocytoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
These data (1) confirm that ART acts as a differentiation factor for autonomic (chiefly sympathoadrenal but also parasympathetic) neurons, (2) suggest a role for ART overexpression in the genesis of pheochromocytomas and paragangliomas, and (3) indicate that ART is not a suitable therapy for peripheral neuropathy.
|
15204970 |
2005 |
Peripheral Nervous System Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
These data (1) confirm that ART acts as a differentiation factor for autonomic (chiefly sympathoadrenal but also parasympathetic) neurons, (2) suggest a role for ART overexpression in the genesis of pheochromocytomas and paragangliomas, and (3) indicate that ART is not a suitable therapy for peripheral neuropathy.
|
15204970 |
2005 |
Anorexia Nervosa
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
Functional analysis of the Ala67Thr polymorphism in agouti related protein associated with anorexia nervosa and leanness.
|
15927146 |
2005 |
Obesity
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
An association study of the AGRP -38C/T SNP and indices of obesity and diabetes status.
|
16130030 |
2006 |
Diabetes Mellitus
|
0.050 |
GeneticVariation
|
group |
BEFREE |
An association study of the AGRP -38C/T SNP and indices of obesity and diabetes status.
|
16130030 |
2006 |
Diabetes
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
An association study of the AGRP -38C/T SNP and indices of obesity and diabetes status.
|
16130030 |
2006 |
Diphtheria
|
0.010 |
Biomarker
|
disease |
BEFREE |
To determine whether NPY/AgRP neurons are essential in mice, we targeted the human diphtheria toxin receptor to the Agrp locus, which allows temporally controlled ablation of NPY/AgRP neurons to occur after an injection of diphtheria toxin.
|
16254186 |
2005 |
Anorexia Nervosa
|
0.070 |
GeneticVariation
|
disease |
LHGDN |
Mutation analysis of the agouti related protein promoter region and the melanocortin-3 receptor in anorexia nervosa patients.
|
16314751 |
2005 |
Cushing Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Plasma AgRP in the patients with Cushing's syndrome following bilateral adrenalectomy and hydrocortisone replacement were similar to the levels seen in controls.
|
16320160 |
2005 |
Adrenal Cushing's syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Plasma AgRP in the patients with Cushing's syndrome following bilateral adrenalectomy and hydrocortisone replacement were similar to the levels seen in controls.
|
16320160 |
2005 |
Malignant Neoplasms
|
0.080 |
Biomarker
|
group |
BEFREE |
The aim of this study was to ascertain whether a genetic alteration of ARTS gene is involved in the development of human cancers possibly by inactivating the apoptotic function of ART.
|
16376484 |
2006 |
Anorexia Nervosa
|
0.070 |
Biomarker
|
disease |
LHGDN |
Plasma agouti-related protein levels in women with anorexia nervosa.
|
16904835 |
2006 |
Anorexia Nervosa
|
0.070 |
Biomarker
|
disease |
BEFREE |
Family trios analysis of common polymorphisms in the obestatin/ghrelin, BDNF and AGRP genes in patients with Anorexia nervosa: association with subtype, body-mass index, severity and age of onset.
|
17197106 |
2007 |
Drug usage
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
Multivariable analysis including age, race, sex, HIV-1 RNA, prior antiretroviral therapy, probable route of infection, prior ADE, absolute CD4, and %CD4 was performed; prior ART (P<.0001), injection-drug use (P=.04), lower absolute CD4 (P=.002), and lower %CD4 (P=.002) predicted disease progression.
|
17205482 |
2007 |
Hepatitis C
|
0.100 |
Biomarker
|
disease |
BEFREE |
The VERSANT HCV RNA 3.0 (bDNA), COBAS AmpliPrep/COBAS TaqMan HCV, and Abbott ART HCV RealTime assays were compared for hepatitis C virus RNA quantification in 158 clinical specimens (genotypes 1 to 5).
|
17581929 |
2007 |
Obesity
|
0.700 |
Biomarker
|
disease |
RGD |
By contrast, although there was the expected increase in both NPY and AGRP expression in obese 14-week-old ZF rats, the expression of NPY and AGRP was decreased in 6-week-old obese ZDF rats with hyperinsulinaemia and in 14-week-old rats with the additional hyperglycaemia.
|
18001323 |
2007 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.210 |
Biomarker
|
disease |
RGD |
Reduced expression of the KATP channel subunit, Kir6.2, is associated with decreased expression of neuropeptide Y and agouti-related protein in the hypothalami of Zucker diabetic fatty rats.
|
18001323 |
2007 |
Obesity
|
0.700 |
Biomarker
|
disease |
BEFREE |
While forced activation of hypothalamic IKKbeta/NF-kappaB interrupts central insulin/leptin signaling and actions, site- or cell-specific suppression of IKKbeta either broadly across the brain or locally within the mediobasal hypothalamus, or specifically in hypothalamic AGRP neurons significantly protects against obesity and glucose intolerance.
|
18854155 |
2008 |
Impaired glucose tolerance
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
While forced activation of hypothalamic IKKbeta/NF-kappaB interrupts central insulin/leptin signaling and actions, site- or cell-specific suppression of IKKbeta either broadly across the brain or locally within the mediobasal hypothalamus, or specifically in hypothalamic AGRP neurons significantly protects against obesity and glucose intolerance.
|
18854155 |
2008 |
Hepatitis C
|
0.100 |
Biomarker
|
disease |
BEFREE |
Twelve of 13 (92%) were receiving ART, with a mean CD4+ count of 428 cells microL(-1) (range 175-928 cells microL(-1)) at initiation of HCV therapy.
|
19187189 |
2009 |
Immunologic Deficiency Syndromes
|
0.080 |
Biomarker
|
group |
BEFREE |
We evaluated NK cell subsets and functions in previously immunodeficient HIV patients responding to ART.
|
19403337 |
2009 |
Obesity
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The aim of the present study was to assess the genetic variability of AGRP gene and investigate whether the previously reported SNP rs5030980 and the rs11575892, a SNP that so far has not been studied with respect to obesity is associated with increased body mass index (BMI).
|
19602223 |
2009 |